Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus

Cornea

Volumn 31, Issue 7, 2012, Pages 786-790

  Sy, Aileen ^a   McLeod, Stephen D ^a   Cohen, Elisabeth J ^b   Margolis, Todd P ^a   Mannis, Mark J ^c   Lietman, Thomas M ^a   Acharya, Nisha R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

herpes zoster ophthalmicus; management; practice patterns; recurrence

Indexed keywords

ACICLOVIR; CORTICOSTEROID; PREDNISOLONE ACETATE; VARICELLA ZOSTER VACCINE;

ANTIVIRAL THERAPY; ARTICLE; CHRONIC DISEASE; CLINICAL PRACTICE; HERPES ZOSTER OPHTHALMICUS; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT INFECTION;

ACYCLOVIR; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; ANTIVIRAL AGENTS; ATTITUDE OF HEALTH PERSONNEL; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HEALTH CARE SURVEYS; HERPES ZOSTER OPHTHALMICUS; HERPES ZOSTER VACCINE; HUMANS; KERATITIS, HERPETIC; OPHTHALMOLOGY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RECURRENCE; TREATMENT OUTCOME;

EID: 84862878974     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31823cbe6a     Document Type: Article

References (34)

1. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2 suppl): S3-S12. (Pubitemid 351173970)
2. Kaufman SC. Anterior segment complications of herpes zoster ophthal-micus. Ophthalmology. 2008;115(2 suppl):S24-S32. (Pubitemid 351173971)
3. Hu AY, Strauss EC, Holland GN, et al. Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus. Am J Ophthalmol. 2010;149:214-220.
4. Piebenga LW, Laibson PR. Dendritic lesions in herpes zoster ophthalmi-cus. Arch Ophthalmol. 1973;90:268-270.
5. Marsh RJ, Cooper M. Ophthalmic zoster: mucous plaque keratitis. Br J Ophthalmol. 1987;71:725-728. (Pubitemid 17148496)
6. Liesegang TJ. Corneal complications from herpes zoster ophthalmicus. Ophthalmology. 1985;92:316-324. (Pubitemid 15099091)
7. Pavan-Langston D, Yamamoto S, Dunkel EC. Delayed herpes zoster pseudodendrites. Polymerase chain reaction detection of viral DNA and a role for antiviral therapy. Arch Ophthalmol. 1995;113:1381-1385.
8. Chern K, Conrad D, Holland G, et al. Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1998;116:1011-1017. (Pubitemid 29101824)
9. Engstrom RE, Holland GN. Chronic herpes zoster virus keratitis associated with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;105:556-558.
10. Al-Muammar A, Jackson WB. Management of ophthalmic zoster mucous plaque keratopathy: report of three cases. Can J Ophthalmol. 2004;39:74-76. (Pubitemid 38325791)
11. Marsh RJ, Fraunfelder FT, McGill JI. Herpetic corneal epithelial disease. Arch Ophthalmol. 1976;94:1899-1902. (Pubitemid 8258103)
12. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20.
13. Ragozzino MW, Melton LJ III, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61: 310-316. (Pubitemid 12031812)
14. Yawn BP, Wollan PC, Kurland MJ, et al. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc. 2011;86:88-93.
15. Mietz H, Eis-Hubinger AM, Sundmacher R, et al. Detection of varicella-zoster virus DNA in keratectomy specimens by use of the polymerase chain reaction. Arch Ophthalmol. 1997;115:590-594. (Pubitemid 27204190)
16. Wenkel H, Rummelt C, Rummelt V, et al. Detection of varicella zoster virus DNA and viral antigen in human cornea after herpes zoster oph-thalmicus. Cornea. 1993;12:131-137. (Pubitemid 23099065)
17. Kido S, Sugita S, Horie S, et al. Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete. Br J Ophthalmol. 2008;92:505-508. (Pubitemid 351497978)
18. Nakashizuka H, Yamazaki Y, Tokumaru M, et al. Varicella-zoster viral antigen identified in iridocyclitis patient. Jpn J Ophthalmol. 2002;46:70-73. (Pubitemid 34195476)
19. Van der Lelij A, Ooijman FM, Kijlstra A, et al. Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases. Ophthalmology. 2000;107:1164-1170.
20. Cobo LM, Foulks GN, Liesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 1986;93:763-770. (Pubitemid 16068346)
21. Gordon YJ. The evolution of antiviral therapy for external ocular viral infections over twenty-five years. Cornea. 2000;19:673-680.
22. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005; 352:2271-2284.
23. Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med. 1995;155:1605-1609.
24. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341-1349. (Pubitemid 350060129)
25. Magone MT, Nasser RE, Cevallos AV, et al. Chronic recurrent varicella-zoster virus keratitis confirmed by polymerase chain reaction testing. Am J Ophthalmol. 2005;139:1135-1136. (Pubitemid 40813341)
26. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med. 1998;339:300-306.
27. Harpaz R, Ortega-Sanchez I, Seward J. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30.
28. Gelb LD. Preventing herpes zoster through vaccination. Ophthalmology. 2008;115(2 suppl):S35-S38. (Pubitemid 351173975)
29. Khalifa YM, Jacoby RM, Margolis TP. Exacerbation of zoster interstitial keratitis after zoster vaccination in an adult. Arch Ophthalmol. 2010;128: 1079-1080.
30. Chang DF, Braga-Mele R, Mamalis N, et al. Clinical experience with intraoperative floppy-iris syndrome. Results of the 2008 ASCRS member survey. J Cataract Refract Surg. 2008;34:1201-1209. (Pubitemid 351847824)
31. Loh AR, Hong K, Lee S, et al. Practice patterns in the management of fungal corneal ulcers. Cornea. 2009;28:856-859.
32. Asbell PA, Spiegel S. Ophthalmologist perceptions regarding treatment of moderate-to-severe dry eye: results of a physician survey. Eye Contact Lens. 2010;36:33-38.
33. Guess SM, Butt AL, Neely SB, et al. Dissemination of knowledge from randomized clinical trials for herpes simplex virus keratitis. Arch Oph-thalmol. 2010;128:1624-1625.
34. Li T, Ervin AM, Scherer R, et al. Setting priorities for comparative effectiveness research: a case study using primary open-angle glaucoma. Ophthalmology. 2010;117:1937-1945.